Zhao Y, Li S, Yang X, Chu L, et al. Overall survival benefit of Osimertinib and clinical value of upfront cranial local therapy in untreated EGFR-mutant non-small cell lung cancer with brain metastasis. Int J Cancer 2021 Dec 16. doi: 10.1002/ijc.33904.
PMID: 34914096